Botanical species · safety record

Anadenanthera peregrina

The EFSA Compendium of Botanicals holds 11 constituent measurements for Anadenanthera peregrina. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Anadenanthera peregrina (L.) Speg.

11Constituent measurements

0Safety records

7Cited sources

0Licensed products (Canada)

Also recorded as

Piptadenia peregrina (L.) Benth

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Indole alkaloids	Seed	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
N,n-dimethyltryptamine	Leaves	Solvent extraction	—	—	Resolve DOI
Alkaloids	—	—	—	GC-MS	No resolvable identifier
Bufotenine	Seed	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Bufotenine	Seed	Solvent extraction	—	Gaschromatography (GC)	No resolvable identifier
Carboline alkaloids	—	—	—	GC-MS	No resolvable identifier
Indole alkaloids	Live plants	—	—	Gaschromatography (GC)	No resolvable identifier
Lectins	Seed	Solvent extraction	—	Indirect hemoagglutination test (IHA)	No resolvable identifier
N,n-dimethyltryptamine	Seed	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
N,n-dimethyltryptamine	Live plants	—	—	Gaschromatography (GC)	No resolvable identifier
Tryptamine alkaloids	Seed	Solvent extraction	—	Gaschromatography (GC)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Blackledge, Robert D., Phelan, Clay P. Identification of bufotenine in yopo seeds via GC/IRD. Microgram journal, 2006, vol. 4(1-4), p. 3-11.
Agurell, Stig., Holmstedt, Bo., Lindgren, Jan E., Schultes, Richard E. Identification of two new beta-carboline alkaloids in South American hallucinogenic plants. Biochemical pharmacology, 1968, vol. 17, no. 12, p. 2487-8.
FELLOWS, LE., BELL, EA. INDOLE METABOLISM IN PIPTADENIA-PEREGRINA. Phytochemistry, 1971, vol. 10, no. 9, p. 2083-&. DOI
Fish, M. S., Johnson, N. M., Horning, E. C. Piptadenia alkaloids. Indole bases of Piptadenia peregrina and related species. Journal of the american chemical society, 1955, vol. 77, p. 5892-5.
Schultes, Richard Evans., Holmstedt, Bo., Lindgren, Jan Erik., Rivier, Laurent. Comments on toxic plants of the tropical new world XVIII. Phytochemical examination of Spruce's ethnobotanical collection of Anadenanthera peregrina. Botanical museum leaflets, harvard university, 1977, vol. 25, no. 10, p. 273-87.
Fernandes, Andreia V., Ramos, Marcio V., Goncalves, Jose Francisco C., Maranhao, Paulo A. C., Chevreuil, Larissa R., Souza, Luiz Augusto G. Seeds of Amazonian Fabaceae as a source of new lectins. Brazilian journal of plant physiology, 2011, vol. 23, no. 3, p. 237-244.
Erhorn, S. Dimethyltryptamine. Xpharm: the comprehensive pharmacology reference, 2011, p. 1-4. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature